Cassava Sciences Halts Alzheimer's Drug Trials After Phase 3 Results
Express News | Corrected-Buzz-U.S. Stocks on the Move-AMC, Alnylam, Super Micro
'Pharma Bro' Martin Shkreli Tells Investors To 'Short SAVA,' Stock Falls Over 80% After Phase 3 Update
Trending Stocks Today | Quantum Shoots up 152.57%
November 25th - US stocks trending in regular trading hours.Gainers: $Quantum(QMCO.US)$ shoots up 152.57% to $23.06 with a turnover of $286.03 million. $QMMM Holdings(QMMM.US)$ surges 50.68% to $1.13
Dow Surges Over 300 Points; Bath & Body Works Posts Upbeat Earnings
U.S. stocks react | Simufilam's phase 3 Alzheimer's trial did not meet its endpoints, leading to a more than 84% plunge in cassava sciences (SAVA.US).
As of the time of publication, the stock has fallen by over 84%, reporting $4.06.